Can early surgical hematoma evacuation in intracerebral hemorrhage (ICH) be done in such a minimally invasive fashion that it promises significantly more benefit than risk?

That’s what Cleveland Clinic and nine other major U.S. medical centers hope to find out by participating in the Early Minimally Invasive Removal of Intracerebral Hemorrhage (ENRICH) study, a phase 3 clinical trial comparing a novel surgical system for clot removal within 24 hours of a hemorrhagic stroke to standard medical management. The system involves specialized devices designed to be manipulated through a small opening in the skull for gentle evacuation of the hematoma with minimal tissue damage.

“Historically, surgery was not a viable option for intracerebral hemorrhage because of damage caused by the surgery itself,” says Mark Bain, MD, a staff neurosurgeon in Cleveland Clinic’s Cerebrovascular Center who’s serving as the site’s principal investigator for the trial. “The system tested in ENRICH offers a minimally disruptive approach to the hematoma, fine control, and a gentle way to remove the hemorrhage. We have high hopes it will prove to be a better treatment for these devastating strokes.”

Read full article. 

 

Share ideas to shape #sustainable solutions for the K+S #BrineChallenge. Join the Challenge and help K+S permanently reduce or eliminate brine run-off from their large potash tailings piles. Learn more here: https://t.co/6Bsx1fu8TT

Can you transform field corn into biobased sustainable products? @NationalCorn wants your help with the #ConsiderCorn Challenge II - find out more and submit your #innovative idea today: https://t.co/Vo11CvdnCq

Congrats to all of @BOMABoston #BostonTOBY winners! Special shout-out to our client bldgs who won last night: One Financial @JLLBoston, One Memorial Drive & 125 Summer Street @OxfordPropGrp, South Street Landing @CushWakeBOSTON, Ballardvale Office Park & 3 Burlington Woods @CBRE